| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 196.71 | 1.6% |
| Total Income | 196.71 | 1.6% |
| Expenditure | 211.14 | 12.9% |
| PBT | -20.83 | 60.0% |
| Net Profit | -20.91 | 60.6% |
| OPM | -7.34% | 17.90pp |
| NPM | -10.63% | 16.79pp |
| EPS | -0.52 | 61.5% |
Orthofix Medical Inc. Announces Spine Leadership Realignment and Preliminary Q1 2026 Net Sales
09 Apr 2026 · 9 Apr, 4:37 pm
Summary
Orthofix Medical Inc. announced a strategic realignment of its Spine leadership team to accelerate profitable growth and sharpen execution. The company also reported preliminary, unaudited net sales results for the first quarter ended March 31, 2026, and reaffirmed its 2026 outlook.
Key Highlights
- 1
Spine leadership streamlined to accelerate decision-making
- 2
Shaeffer Bannigan assumes expanded role as Leader, Spinal Solutions
- 3
Patrick Fisher assumes leadership of the Company’s Biologics business
Management Comments
M
Massimo Calafiore
These updates further clarify leadership alignment and ownership
Informational and educational content only. Not investment advice.